Latest News and Press Releases

Vantage Biosciences completes enrollment in the Phase 2 SeeClear study of oral oruvestat in non-proliferative diabetic retinopathy.

AMSilk collaboration: Biotech silk protein yarns feature in Balenciaga 55th Couture Collection

Molecure's Phase II KITE trial for OATD-01 in pulmonary sarcoidosis will continue without protocol changes following a positive IDMC review.

San Francisco, California, USA, Aug. 03, 2026 (GLOBE NEWSWIRE) -- US Capital Global Securities LLC, the SEC-registered broker-dealer affiliate of the global financial group US Capital Global, is...

First-in-class pan-RAS(ON) ADC is cleared for clinical development Designed to selectively deliver pan-RAS(ON) inhibition to tumors while minimizing systemic toxicity. IND submissions to U.S. FDA...

BCC Research analyzes innovations, trends, competition and regional opportunities shaping single-use technologies in biopharma manufacturing.

Limagrain and leading genome editing player Beijing Qi Biodesign Biotechnology Co., Ltd. ("Qi Biodesign") today announced a global licensing agreement granting Limagrain access to a portfolio of...

VANCOUVER, BC and BOSTON, MA, July 30, 2026 (GLOBE NEWSWIRE) -- Xenon Pharmaceuticals Inc. (Nasdaq: XENE), a neuroscience-focused biopharmaceutical company dedicated to drug discovery, clinical...

Kneat shareholders overwhelmingly support transaction with Thoma Bravo in special meeting vote.

MNKD Reports Positive Phase 1b INFLO-1 Results, Demonstrating Safety & Tolerability of Nintedanib DPI and Clinical Validation of Its DPI Technology in IPF